back to top
HomeTagsIND

IND

GC Biopharma/Novel Pharma's Sanfilippo Syndrome Therapy Obtains FDA IND Approval By Investing.com

YONGIN, South Korea, Could 20, 2024 /PRNewswire/ -- GC Biopharma (006280. KS) and Novel  Pharma introduced that its collectively developed MPS IIIA 'GC1130A' remedy...

Most Popular

spot_img